GRDN

Guardian Pharmacy Services, Inc.

• Simply Wall St·4d ago

  What Guardian Pharmacy Services (GRDN)'s Q1 Beat, Steady Guidance and New Equity Shelf Mean For Shareholders

• Simply Wall St·6d ago

  Assessing Guardian Pharmacy Services (GRDN) Valuation After Earnings With One-Off Items And Reaffirmed Revenue Outlook

• TipRanks·05/11 00:28

  Guardian Pharmacy Services Signals Strength Amid IRA Shock

• Simply Wall St·05/09 17:51

  Should Guardian Pharmacy’s Strong Q1 and Higher EBITDA Guidance Amid Cost Pressures Prompt Action From GRDN Investors?

• TipRanks·05/07 20:54

  Guardian Pharmacy Stockholders Back Directors, Pay and Auditor

• TipRanks·05/07 14:26

  Guardian Pharmacy price target raised to $43 from $38 at Oppenheimer

• TipRanks·05/07 13:21

  Analysts Offer Insights on Healthcare Companies: Guardian Pharmacy Services, Inc. Class A (GRDN), biote (BTMD) and Argenx Se (ARGX)

• Dow Jones·05/07 13:10

  Guardian Pharmacy Svcs Price Target Raised to $43.00/Share From $38.00 by Oppenheimer

• Dow Jones·05/07 13:10

  Guardian Pharmacy Svcs Is Maintained at Outperform by Oppenheimer

• Benzinga·05/07 12:59

  Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43

• Seeking Alpha·05/07 12:45

  Guardian Pharmacy Services Non-GAAP EPS of $0.29 beats by $0.05, revenue of $336.6M beats by $6.71M

• TipRanks·05/07 10:37

  Guardian Pharmacy Services, Inc. Class A (GRDN) Receives a Buy from Bank of America Securities

• TipRanks·05/07 01:02

  Guardian Pharmacy files automatic Class A common stock offering

• TipRanks·05/07 00:54

  Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B

• Seeking Alpha·05/06 23:52

  Guardian Pharmacy Services forecasts $123M-$127M adjusted EBITDA amid ira pricing reset